Picture Demy-Colton BioFuture 2021 NYC A October 650x80px
Document › Details

Agilent Technologies Inc.. (1/22/18). "Press Release: Agilent Named Company of the Year by Instrument Business Outlook". Santa Clara, CA.

Organisation Organisation Strategic Directions International Inc. (SDI)
  Group Bioinformatics LLC
Products Product analytical instrument
  Product 2 Instrument Business Outlook (IBO)
Persons Person Samazan, Tanya (Bioinformatics LLC 201801 Managing Editor of Insrument Business Look)
  Person 2 McMullen, Mike (Agilent 201409– COO + designated CEO for 3/15 before SVP + President Chemical Analysis Group)

Industry Newsletter Cites Technology Development, Operational and Financial Performance

Agilent Technologies Inc. (NYSE: A) today announced that it has been selected as 2017 Company of the Year by Instrument Business Outlook (IBO).

IBO is a respected industry newsletter that tracks trends in the laboratory products markets, monitoring hundreds of life science and analytical instrument companies on a daily basis.

Managing Editor Tanya Samazan noted: "Agilent has grown sales since fiscal 2015 while keeping costs constant. The company's fiscal 2017 revenue growth was its fastest since fiscal 2010. Agilent's new investments have also paid off. Changes include an expansion of Agilent's diagnostics business, entry into new markets such as cell analysis and Raman spectroscopy, and additions to successful franchises in NGS sample preparation and LC/MS, among other key product launches."

"We are pleased that IBO has recognized Agilent as their 2017 Company of the Year, citing our impressive growth," said Mike McMullen, Agilent's president and CEO. "Having the right strategy to secure growth is pivotal, but equally crucial is the right team, resolute in their commitment, and with one focus - to provide solutions and services which enable Agilent´s customers to be successful across the all the markets we serve."

The newsletter highlighted Agilent's increased growth in revenues, operating profit, and net income, noting that the gains were the result of a sustained effort to position the company for future growth.

"It is rewarding that an organization with an in-depth knowledge of the industry, such as IBO, recognizes Agilent´s current strategy is the right one resulting in consistent growth," said Patrick Kaltenbach, president of Agilent's Life Sciences and Applied Markets Group. "Growth fueled by our focus on Innovation with Purpose, introducing differentiated solutions to address customer needs, and our strong Operational Excellence in developing, manufacturing and commercialization of our products, all complemented by our recent acquisitions."

IBO is a twice-monthly publication of SDi, a division of BioInformatics LLC, which offers custom market research and consulting, and strategic advisory services. IBO will present the award to Agilent at the annual conference of the Society for Laboratory Automation and Screening (SLAS) in San Diego in early February.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 13,500 people worldwide. Information about Agilent is available at


Victoria Wadsworth-Hansen
Agilent Technologies
+1 408 553 2005
+45 2933 6980

Record changed: 2018-01-30


Picture Berlin Partner Berlin-Brandenburg Healthcare Industries Cluster 650x80px

More documents for Agilent (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px

» top